NovaBridge Biosciences Increase (Decrease) in Other Operating Liabilities
NovaBridge Biosciences (NBP) reported Increase (Decrease) in Other Operating Liabilities of CNY 53.15 million for the 12-month period ending 2019-12-31, per its 20-F filed 2022-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2022-04-29
- NovaBridge Biosciences increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was 941.00K CNY.
CNY
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|
| 2019-12-31 | 941.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 53.15M CNY 20-F · filed 2022-04-29 | |
| 2019-09-30 | 52.21M CNY 6-K · filed 2021-02-05 | ||
| 2018-12-31 | 178.72M CNY 20-F · filed 2021-04-28 |
USD
| Period end | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|
| 2019-12-31 | $7.63M 20-F · filed 2020-04-29 |